Brighton Pharmaceuticals

Brighton's experienced development staff has been a key contributor to the firm's rapid success. In its 1st year of commercial sales, Brighton launched 18 products and started actively pursuing numerous line additions for the near future. Brighton's current product portfolio consists of liquids, capsules and tablets. In order to continue meeting the requirements of the rapidly evolving generic prescription markets, Brighton has invested significant resources in the immediate pursuit and development of ANDA products.